Crohn's disease but not ulcerative colitis elevated risk of end-stage renal disease and mortality: A Taiwan retrospective cohort study

克罗恩病而非溃疡性结肠炎会增加终末期肾病和死亡的风险:一项台湾回顾性队列研究

阅读:1

Abstract

Inflammatory bowel disease (IBD) is an autoinflammatory disease which may affect extraintestinal organs, including kidney. However, rare research showed that patients with IBD have higher risk of end-stage renal disease (ESRD). Furthermore, lack of studies compared the potential risk of ESRD and mortality among patients with ulcerative colitis (UC) and Crohn disease (CD). We conducted a nationwide cohort study using the National Health Insurance database in Taiwan, from January 2008 to December 2018. A total of 3204 patients diagnosed with IBD were enrolled. IBD cases were identified through the presence of a catastrophic illness certificate, including CD and UC. The study outcomes were the incidence of ESRD and mortality. ESRD diagnosis required a serious illness certificate and was identified using the corresponding ICD-10-CM codes. Mortality was recorded in the Taiwan Death Registry linked with the National Health Insurance database, Cox proportional hazards models were used to estimate the risk factors for ESRD and mortality among IBD patients. CD patients had a significantly higher risk of ESRD (adjust hazard ratio: 2.32, 95% confidence interval: 1.28-4.18) and mortality (adjust hazard ratio: 1.80, 95% confidence interval: 1.37-2.35) compared to healthy individuals. UC patients showed no difference in the risk of ESRD compared to healthy individuals. Instead, among IBD patients, UC poses a relatively lower risk for ESRD compared to other factors like age and other comorbidities. Elevated risk of ESRD and mortality was only noted in patients with CD but not UC. Surprisingly, UC patients had lower risk of ESRD and mortality than CD patients. These findings highlight distinctive patterns of risk associated with CD and UC, emphasizing the importance of considering disease subtype when assessing outcomes such as ESRD and mortality.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。